Study for Safety and Tolerability of TOP1288 Administered Orally in Healthy Subjects

NCT03071081 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

37

Enrollment

INDUSTRY

Sponsor class

Conditions

Ulcerative Colitis

Interventions

DRUG: TOP1288
DRUG: Placebo to TOP1288

Sponsor

Topivert Pharma Ltd